Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alignment Healthcare (ALHC) Other Non Operating Income (2020 - 2025)

Alignment Healthcare's Other Non Operating Income history spans 6 years, with the latest figure at -$89000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 97.12% year-over-year to -$89000.0; the TTM value through Sep 2025 reached -$3.0 million, down 369.95%, while the annual FY2024 figure was -$3.0 million, N/A changed from the prior year.
  • Other Non Operating Income reached -$89000.0 in Q4 2025 per ALHC's latest filing, down from $79000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $13.7 million in Q4 2022 to a low of -$6.7 million in Q3 2022.
  • Average Other Non Operating Income over 5 years is -$1.3 million, with a median of -$400000.0 recorded in 2023.
  • Peak YoY movement for Other Non Operating Income: skyrocketed 414.74% in 2022, then crashed 334.88% in 2024.
  • A 5-year view of Other Non Operating Income shows it stood at -$4.4 million in 2021, then surged by 414.74% to $13.7 million in 2022, then crashed by 105.17% to -$711000.0 in 2023, then plummeted by 334.88% to -$3.1 million in 2024, then surged by 97.12% to -$89000.0 in 2025.
  • Per Business Quant, the three most recent readings for ALHC's Other Non Operating Income are -$89000.0 (Q4 2025), $79000.0 (Q2 2025), and $10000.0 (Q1 2025).